Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gene Mutations”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02876939
What this trial is testing

Proprioception and Sensorimotor Control in Hereditary Sensory and Autonomic Neuropathy

Who this might be right for
Atunomic Neuropathy
NYU Langone Health 16
Not applicableActive Not RecruitingNCT03892980
What this trial is testing

Robotic-Assisted da Vinci System Prophylactic Nipple-Sparing Mastectomy

Who this might be right for
Nipple Sparing Mastectomy
Intuitive Surgical 145
Not applicableActive Not RecruitingNCT03546972
What this trial is testing

Diabetes Prevention Program With or Without Hunger Training in Helping to Lower Breast Cancer Risk in Obese Participants

Who this might be right for
Deleterious BRCA1 Gene MutationDeleterious BRCA2 Gene MutationDuctal Breast Carcinoma In Situ+3 more
M.D. Anderson Cancer Center 51
Testing effectiveness (Phase 2)Active Not RecruitingNCT03839342
What this trial is testing

Binimetinib and Encorafenib for the Treatment of Advanced Solid Tumors With Non-V600E BRAF Mutations

Who this might be right for
Solid Tumor
University Health Network, Toronto 26
Not applicableStudy completedNCT02761473
What this trial is testing

Cutaneous Mastocytosis in Children: Analysis of Somatic and Germline Mutations

Who this might be right for
Urticaria PigmentosaCutaneous Mastocytosis
University of Minnesota 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07670156
What this trial is testing

Upadacitinib in Treatment of JAK/STAT Pathway Disorders With Activating Mutations

Who this might be right for
JAK1 GOFSTAT1 GOFSTAT3 GOF+2 more
Lisa Satter 30
Testing effectiveness (Phase 2)Study completedNCT02064569
What this trial is testing

Safety Evaluation of Gene Therapy in Leber Hereditary Optic Neuropathy (LHON) Patients

Who this might be right for
Leber Hereditary Optic Neuropathy
GenSight Biologics 19
Large-scale testing (Phase 3)UnknownNCT01407822
What this trial is testing

Erlotinib Versus Gemcitabine/Cisplatin as (Neo)Adjuvant Treatment in Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Guangdong Association of Clinical Trials 72
Testing effectiveness (Phase 2)UnknownNCT01312337
What this trial is testing

Iressa for EGFR Mutation Negative Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Nonsmall Cell Lung Cancer
Samsung Medical Center 92
Post-approval studies (Phase 4)Study completedNCT01297777
What this trial is testing

Imatinib in KIT-negative Systemic Mastocytosis

Who this might be right for
Systemic Mastocytosis
Hospital Virgen de la Salud 10
Not applicableActive Not RecruitingNCT07506083
What this trial is testing

Natural History in Fabry Disease With IVS4+919G>A Mutations

Who this might be right for
Fabry Disease
Chinese University of Hong Kong 31
Not applicableLooking for participantsNCT07413029
What this trial is testing

French National Cohort of Patients With PRSS1 Mutations

Who this might be right for
Hereditary PancreatitisPRSS1 Gene Mutation
Assistance Publique - Hôpitaux de Paris 800
Testing effectiveness (Phase 2)Active Not RecruitingNCT06212583
What this trial is testing

High-Risk Metachronous Oligometastatic Prostate Cancer Trial

Who this might be right for
Prostate CancerOligometastatic Disease
University of Maryland, Baltimore 88
Not applicableUnknownNCT03582241
What this trial is testing

NGS in AML Relapse

Who this might be right for
Acute Myeloid Leukemia
University Hospital, Strasbourg, France 40
Not applicableStudy completedNCT05902494
What this trial is testing

HER2 and LA/mUC: A Multi-country Chart Review Cohort Study

Who this might be right for
Urothelial Carcinoma
Seagen, a wholly owned subsidiary of Pfizer 389
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06736080
What this trial is testing

Safety and Efficacy of Gene Therapy of FHL Type 3 Caused by Mutations in the Human UNC13D Gene by Transplantation of a Single Dose of Autologous CD34+ Cells Transduced ex Vivo With the UNC13D LV Vector Expressing the UNC13D cDNA

Who this might be right for
Familial Hemophagocytic Lymphohistiocytosis Type 3 (FHL 3)
Assistance Publique - Hôpitaux de Paris 5
Testing effectiveness (Phase 2)Looking for participantsNCT06945705
What this trial is testing

A Clinical Trial of Furmonertinib Combined With Anlotinib as First-line Treatment for Advanced NSCLC With EGFR-sensitive Mutations and Brain Metastasis

Who this might be right for
NSCLC
Henan Cancer Hospital 146
Early research (Phase 1)Study completedNCT02388594
What this trial is testing

A Phase I Study of T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728mR in HIV-Infected Patients

Who this might be right for
Human Immunodeficiency Virus (HIV)
University of Pennsylvania 14
Testing effectiveness (Phase 2)Study completedNCT05287503
What this trial is testing

Ambroxol as a Disease-modifying Treatment in GBA-PD

Who this might be right for
Parkinson DiseaseGBA Gene Mutation
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 65
Large-scale testing (Phase 3)Looking for participantsNCT06380751
What this trial is testing

Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer

Who this might be right for
Advanced Breast Cancer
AstraZeneca 788
Next Page